Chemoprevention of colorectal cancer: A role for ursodeoxycholic acid, folate and hormone replacement treatment?

Best Practice and Research: Clinical Gastroenterology

Volumn 25, Issue 4-5, 2011, Pages 555-568

  Solimando, Riccardo ^a   Bazzoli, Franco ^a   Ricciardiello, Luigi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Chemoprevention; Colorectal cancer; Folate; Folic acid; Hormone replacement treatment; UDCA; Ursodeoxycholic acid

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; FOLIC ACID; MEDROXYPROGESTERONE ACETATE; PROGESTERONE; URSODEOXYCHOLIC ACID; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ARTICLE; COLON CARCINOGENESIS; COLORECTAL CANCER; DNA METHYLATION; DNA POLYMORPHISM; DRUG MECHANISM; EPIDEMIOLOGICAL DATA; FAMILIAL CANCER; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; INFLAMMATION; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; RISK ASSESSMENT; UNSPECIFIED SIDE EFFECT;

ANIMALS; ANTICARCINOGENIC AGENTS; CHEMOPREVENTION; COLORECTAL NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FOLIC ACID; HUMANS; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 82455188345     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2011.09.004     Document Type: Article

References (98)

1. J.H. Weisburger, and E.L. Wynder Etiology of colorectal cancer with emphasis on mechanism of action and prevention Important Adv Oncol 1987 197 220
2. F. Bazzoli, H. Fromm, R.P. Sarva, R.F. Sembrat, and S. Ceryak Comparative formation of lithocholic acid from chenodeoxycholic and ursodeoxycholic acids in the colon Gastroenterology 83 4 1982 753 760 (Pubitemid 12060511)
3. C.H. Imray, S. Radley, A. Davis, G. Barker, C.W. Hendrickse, and I.A. Donovan Faecal unconjugated bile acids in patients with colorectal cancer or polyps Gut 33 9 1992 1239 1245
4. E. Bayerdorffer, G.A. Mannes, W.O. Richter, T. Ochsenkuhn, B. Wiebecke, and W. Kopcke Increased serum deoxycholic acid levels in men with colorectal adenomas Gastroenterology 104 1 1993 145 151 (Pubitemid 23040017)
5. T. Hori, K. Matsumoto, Y. Sakaitani, M. Sato, and M. Morotomi Effect of dietary deoxycholic acid and cholesterol on fecal steroid concentration and its impact on the colonic crypt cell proliferation in azoxymethane-treated rats Cancer Lett 124 1 1998 79 84 (Pubitemid 28073812)
6. E. Roda, F. Bazzoli, A.M. Labate, G. Mazzella, A. Roda, and C. Sama Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomised study Hepatology 2 6 1982 804 810 (Pubitemid 13204372)
7. B.Y. Tung, M.J. Emond, R.C. Haggitt, M.P. Bronner, M.B. Kimmey, and K.V. Kowdley Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis Ann Intern Med 134 2 2001 89 95 (Pubitemid 32096335)
8. D.S. Pardi, E.V. Loftus Jr., W.K. Kremers, J. Keach, and K.D. Lindor Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis Gastroenterology 124 4 2003 889 893 (Pubitemid 36389790)
9. L. Serfaty, L.A. De, O. Rosmorduc, B. Desaint, J.F. Flejou, and O. Chazouilleres Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study Hepatology 38 1 2003 203 209 (Pubitemid 36775812)
10. K. Shetty, L. Rybicki, A. Brzezinski, W.D. Carey, and B.A. Lashner The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis Am J Gastroenterol 94 6 1999 1643 1649 (Pubitemid 29260459)
11. J.M. Wolf, L.A. Rybicki, and B.A. Lashner The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis Aliment Pharmacol Ther 22 9 2005 783 788 (Pubitemid 41564357)
12. D.L. Earnest, H. Holubec, R.K. Wali, C.S. Jolley, M. Bissonette, and A.K. Bhattacharyya Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid Cancer Res 54 19 1994 5071 5074
13. R.F. Jacoby, C.E. Cole, E.T. Hawk, and R.A. Lubet Ursodeoxycholate/ Sulindac combination treatment effectively prevents intestinal adenomas in a mouse model of polyposis Gastroenterology 127 3 2004 838 844 (Pubitemid 39208416)
14. H. Kohno, R. Suzuki, Y. Yasui, S. Miyamoto, K. Wakabayashi, and T. Tanaka Ursodeoxycholic acid versus sulfasalazine in colitis-related colon carcinogenesis in mice Clin Cancer Res 13 8 2007 2519 2525 (Pubitemid 46698605)
15. J.D. Martinez, E.D. Stratagoules, J.M. LaRue, A.A. Powell, P.R. Gause, and M.T. Craven Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation Nutr Cancer 31 2 1998 111 118 (Pubitemid 28428071)
16. J.D. Amaral, R.J. Viana, R.M. Ramalho, C.J. Steer, and C.M. Rodrigues Bile acids: regulation of apoptosis by ursodeoxycholic acid J Lipid Res 50 9 2009 1721 1734
17. S. Yui, R. Kanamoto, and T. Saeki Deoxycholic acid can induce apoptosis in the human colon cancer cell line HCT116 in the absence of Bax Nutr Cancer 60 1 2008 91 96 (Pubitemid 351186219)
18. S. Jean-Louis, S. Akare, M.A. Ali, E.A. Mash Jr., E. Meuillet, and J.D. Martinez Deoxycholic acid induces intracellular signaling through membrane perturbations J Biol Chem 281 21 2006 14948 14960 (Pubitemid 43855199)
19. A.A. Powell, J.M. LaRue, A.K. Batta, and J.D. Martinez Bile acid hydrophobicity is correlated with induction of apoptosis and/or growth arrest in HCT116 cells Biochem J 356 Pt 2 2001 481 486 (Pubitemid 32532359)
20. D.S. Alberts, M.E. Martinez, L.M. Hess, J.G. Einspahr, S.B. Green, and A.K. Bhattacharyya Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence J Natl Cancer Inst 97 11 2005 846 853 (Pubitemid 40909127)
21. R. Feldman, and J.D. Martinez Growth suppression by ursodeoxycholic acid involves caveolin-1 enhanced degradation of EGFR Biochim Biophys Acta 1793 8 2009 1387 1394
22. S.A. Shah, Y. Volkov, Q. Arfin, M.M. bdel-Latif, and D. Kelleher Ursodeoxycholic acid inhibits interleukin 1 beta [corrected] and deoxycholic acid-induced activation of NF-kappaB and AP-1 in human colon cancer cells Int J Cancer 118 3 2006 532 539 (Pubitemid 43076000)
23. B.W. Katona, S. Anant, D.F. Covey, and W.F. Stenson Characterization of enantiomeric bile acid-induced apoptosis in colon cancer cell lines J Biol Chem 284 5 2009 3354 3364
24. S. Khare, S. Cerda, R.K. Wali, F.C. von Lintig, M. Tretiakova, and L. Joseph Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer Cancer Res 63 13 2003 3517 3523 (Pubitemid 36793030)
25. R.K. Wali, S. Khare, M. Tretiakova, G. Cohen, L. Nguyen, and J. Hart Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin Cancer Epidemiol Biomark Prev 11 12 2002 1653 1662 (Pubitemid 36020020)
26. S. Khare, R. Mustafi, S. Cerda, W. Yuan, S. Jagadeeswaran, and U. Dougherty Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer: roles of Ras, p38, and CCAAT/enhancer-binding protein Nutr Cancer 60 3 2008 389 400 (Pubitemid 351601376)
27. Y. Kawamata, R. Fujii, M. Hosoya, M. Harada, H. Yoshida, and M. Miwa A G protein-coupled receptor responsive to bile acids J Biol Chem 278 11 2003 9435 9440 (Pubitemid 36800434)
28. S. Modica, S. Murzilli, L. Salvatore, D.R. Schmidt, and A. Moschetta Nuclear bile acid receptor FXR protects against intestinal tumorigenesis Cancer Res 68 23 2008 9589 9594
29. R.R. Maran, A. Thomas, M. Roth, Z. Sheng, N. Esterly, and D. Pinson Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development J Pharmacol Exp Ther 328 2 2009 469 477
30. U. Sjoqvist, B. Tribukait, A. Ost, C. Einarsson, L. Oxelmark, and R. Lofberg Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study Anticancer Res 24 5B 2004 3121 3127 (Pubitemid 39390961)
31. P.A. Thompson, B.C. Wertheim, D.J. Roe, E.L. Ashbeck, E.T. Jacobs, and P. Lance Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients Cancer Prev Res (Phila) 2 12 2009 1023 1030
32. J.E. Eaton, M.G. Silveira, D.S. Pardi, E. Sinakos, K.V. Kowdley, and V.A. Luketic High-Dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis Am J Gastroenterol 2011
33. J.B. Mason, A. Dickstein, P.F. Jacques, P. Haggarty, J. Selhub, and G. Dallal A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis Cancer Epidemiol Biomark Prev 16 7 2007 1325 1329 (Pubitemid 47076861)
34. B.A. Lashner, K.S. Provencher, D.L. Seidner, A. Knesebeck, and A. Brzezinski The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis Gastroenterology 112 1 1997 29 32 (Pubitemid 27008982)
35. M.L. Cravo, J.B. Mason, Y. Dayal, M. Hutchinson, D. Smith, and J. Selhub Folate deficiency enhances the development of colonic neoplasia in dimethylhydrazine-treated rats Cancer Res 52 18 1992 5002 5006
36. Y.I. Kim, R.N. Salomon, F. Graeme-Cook, S.W. Choi, D.E. Smith, and G.E. Dallal Dietary folate protects against the development of macroscopic colonic neoplasia in a dose responsive manner in rats Gut 39 5 1996 732 740 (Pubitemid 26426477)
37. D.A. Kennedy, S.J. Stern, M. Moretti, I. Matok, M. Sarkar, and C. Nickel Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis Cancer Epidemiol 35 1 2011 2 10
38. E. Giovannucci, E.B. Rimm, A. Ascherio, M.J. Stampfer, G.A. Colditz, and W.C. Willett Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men J Natl Cancer Inst 87 4 1995 265 273
39. E. Giovannucci, M.J. Stampfer, G.A. Colditz, D.J. Hunter, C. Fuchs, and B.A. Rosner Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study Ann Intern Med 129 7 1998 517 524 (Pubitemid 28460290)
40. E.J. Jacobs, C.J. Connell, A.V. Patel, A. Chao, C. Rodriguez, and J. Seymour Multivitamin use and colon cancer mortality in the cancer prevention study II cohort (United States) Cancer Causes Control 12 10 2001 927 934 (Pubitemid 34048874)
41. D.H. Kim, S.A. Smith-Warner, D. Spiegelman, S.S. Yaun, G.A. Colditz, and J.L. Freudenheim Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer Cancer Causes Control 21 11 2010 1919 1930
42. E.M. van, and J.G. Herman Viewing the epigenetics of colorectal cancer through the window of folic acid effects Cancer Prev Res (Phila) 3 12 2010 1509 1512
43. G.B. Van, J. Hultdin, I. Johansson, G. Hallmans, R. Stenling, and E. Riboli Low folate levels may protect against colorectal cancer Gut 55 10 2006 1461 1466 (Pubitemid 44476792)
44. S. Hirsch, H. Sanchez, C. Albala, M.P. de la Maza, G. Barrera, and L. Leiva Colon cancer in Chile before and after the start of the flour fortification program with folic acid Eur J Gastroenterol Hepatol 21 4 2009 436 439
45. J.E. Lee, W.C. Willett, C.S. Fuchs, S.A. Smith-Warner, K. Wu, and J. Ma Folate intake and risk of colorectal cancer and adenoma: modification by time Am J Clin Nutr 93 4 2011 817 825
46. V.L. Stevens, M.L. McCullough, J. Sun, E.J. Jacobs, P.T. Campbell, and S.M. Gapstur High levels of folate from supplements and fortification are not associated with increased risk of colorectal cancer Gastroenterology 141 1 2011 98 105
47. J.W. Crott, Z. Liu, S.W. Choi, and J.B. Mason Folate depletion in human lymphocytes up-regulates p53 expression despite marked induction of strand breaks in exons 5-8 of the gene Mutat Res 626 1-2 2007 171 179 (Pubitemid 44881413)
48. K.C. Kim, H. Jang, J. Sauer, E.M. Zimmerly, Z. Liu, and A. Chanson Folate supplementation differently affects uracil content in DNA in the mouse colon and liver Br J Nutr 105 5 2011 688 693
49. S.W. Choi, Y.I. Kim, J.N. Weitzel, and J.B. Mason Folate depletion impairs DNA excision repair in the colon of the rat Gut 43 1 1998 93 99 (Pubitemid 28335495)
50. Y.I. Kim Folate and colorectal cancer: an evidence-based critical review Mol Nutr Food Res 51 3 2007 267 292
51. M. Esteller Relevance of DNA methylation in the management of cancer Lancet Oncol 4 6 2003 351 358 (Pubitemid 36748422)
52. J. Sauer, H. Jang, E.M. Zimmerly, K.C. Kim, Z. Liu, and A. Chanson Ageing, chronic alcohol consumption and folate are determinants of genomic DNA methylation, p16 promoter methylation and the expression of p16 in the mouse colon Br J Nutr 104 1 2010 24 30
53. P. Protiva, J.B. Mason, Z. Liu, M.E. Hopkins, C. Nelson, and J.R. Marshall Altered folate availability modifies the molecular environment of the human colorectum: implications for colorectal carcinogenesis Cancer Prev Res (Phila) 4 4 2011 530 543
54. J.C. Figueiredo, M.V. Grau, K. Wallace, A.J. Levine, L. Shen, and R. Hamdan Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors Cancer Epidemiol Biomark Prev 18 4 2009 1041 1049
55. P. Frosst, H.J. Blom, R. Milos, P. Goyette, C.A. Sheppard, and R.G. Matthews A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase Nat Genet 10 1 1995 111 113
56. S.J. Eussen, S.E. Vollset, J. Igland, K. Meyer, A. Fredriksen, and P.M. Ueland Plasma folate, related genetic variants, and colorectal cancer risk in EPIC Cancer Epidemiol Biomark Prev 19 5 2010 1328 1340
57. S.W. Choi, and J.B. Mason Folate status: effects on pathways of colorectal carcinogenesis J Nutr 132 8 Suppl 2002 2413S 2418S (Pubitemid 34848118)
58. G.M. Lindzon, A. Medline, K.J. Sohn, F. Depeint, R. Croxford, and Y.I. Kim Effect of folic acid supplementation on the progression of colorectal aberrant crypt foci Carcinogenesis 30 9 2009 1536 1543
59. J. Song, A. Medline, J.B. Mason, S. Gallinger, and Y.I. Kim Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse Cancer Res 60 19 2000 5434 5440
60. R. Jaszewski, S. Misra, M. Tobi, N. Ullah, J.A. Naumoff, and O. Kucuk Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial World J Gastroenterol 14 28 2008 4492 4498
61. K. Wu, E.A. Platz, W.C. Willett, C.S. Fuchs, J. Selhub, and B.A. Rosner A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma Am J Clin Nutr 90 6 2009 1623 1631
62. R.F. Logan, M.J. Grainge, V.C. Shepherd, N.C. Armitage, and K.R. Muir Aspirin and folic acid for the prevention of recurrent colorectal adenomas Gastroenterology 134 1 2008 29 38 (Pubitemid 350309319)
63. B.F. Cole, J.A. Baron, R.S. Sandler, R.W. Haile, D.J. Ahnen, and R.S. Bresalier Folic acid for the prevention of colorectal adenomas: a randomized clinical trial JAMA 297 21 2007 2351 2359 (Pubitemid 46883748)
64. J.C. Figueiredo, A.J. Levine, M.V. Grau, E.L. Barry, P.M. Ueland, and D.J. Ahnen Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels Cancer Epidemiol Biomark Prev 17 10 2008 2625 2631
65. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics CA Cancer J Clin 60 5 2010 277 300
66. A.J. McMichael, and J.D. Potter Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis J Natl Cancer Inst 65 6 1980 1201 1207 (Pubitemid 11196006)
67. K.J. Wernli, Y. Wang, Y. Zheng, J.D. Potter, and P.A. Newcomb The relationship between gravidity and parity and colorectal cancer risk J Womens Health (Larchmt) 18 7 2009 995 1001
68. F. Grodstein, P.A. Newcomb, and M.J. Stampfer Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis Am J Med 106 5 1999 574 582 (Pubitemid 29231110)
69. F. Grodstein, M.E. Martinez, E.A. Platz, E. Giovannucci, G.A. Colditz, and M. Kautzky Postmenopausal hormone use and risk for colorectal cancer and adenoma Ann Intern Med 128 9 1998 705 712 (Pubitemid 28204861)
70. K. Woodson, E. Lanza, J.A. Tangrea, P.S. Albert, M. Slattery, and J. Pinsky Hormone replacement therapy and colorectal adenoma recurrence among women in the polyp prevention trial J Natl Cancer Inst 93 23 2001 1799 1805 (Pubitemid 33150452)
71. M.L. Slattery, R. Ballard-Barbash, S. Edwards, B.J. Caan, and J.D. Potter Body mass index and colon cancer: an evaluation of the modifying effects of oestrogen (United States) Cancer Causes Control 14 1 2003 75 84 (Pubitemid 36403272)
72. I. Csizmadi, J.P. Collet, A. Benedetti, J.F. Boivin, and J.A. Hanley The effects of transdermal and oral oestrogen replacement therapy on colorectal cancer risk in postmenopausal women Br J Cancer 90 1 2004 76 81 (Pubitemid 38174942)
73. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, and M.L. Stefanick Risks and benefits of oestrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial JAMA 288 3 2002 321 333 (Pubitemid 34761611)
74. P.A. Newcomb, Y. Zheng, V.M. Chia, L.M. Morimoto, V.P. Doria-Rose, and A. Templeton Oestrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women Cancer Res 67 15 2007 7534 7539 (Pubitemid 47206584)
75. J.S. Hildebrand, E.J. Jacobs, P.T. Campbell, M.L. McCullough, L.R. Teras, and M.J. Thun Colorectal cancer incidence and postmenopausal hormone use by type, recency, and duration in cancer prevention study II Cancer Epidemiol Biomark Prev 18 11 2009 2835 2841
76. H.K. Delellis, L. Duan, J. Sullivan-Halley, H. Ma, C.A. Clarke, and S.L. Neuhausen Menopausal hormone therapy use and risk of invasive colon cancer: the California teachers study Am J Epidemiol 171 4 2010 415 425
77. J.R. Johnson, J.V. Lacey Jr., D. Lazovich, M.A. Geller, C. Schairer, and A. Schatzkin Menopausal hormone therapy and risk of colorectal cancer Cancer Epidemiol Biomark Prev 18 1 2009 196 203
78. K.K. Tsilidis, N.E. Allen, T.J. Key, M.A. Sanjoaquin, K. Bakken, and F. Berrino Menopausal hormone therapy and risk of colorectal cancer in the European prospective investigation into cancer and nutrition Int J Cancer 128 8 2011 1881 1889
79. A. Zervoudakis, H.D. Strickler, Y. Park, X. Xue, A. Hollenbeck, and A. Schatzkin Reproductive history and risk of colorectal cancer in postmenopausal women J Natl Cancer Inst 103 10 2011 826 834
80. M. Marino, P. Galluzzo, and P. Ascenzi Oestrogen signaling multiple pathways to impact gene transcription Curr Genomics 7 8 2006 497 508 (Pubitemid 46068961)
81. O. Wada-Hiraike, O. Imamov, H. Hiraike, K. Hultenby, T. Schwend, and Y. Omoto Role of oestrogen receptor beta in colonic epithelium Proc Natl Acad Sci U S A 103 8 2006 2959 2964
82. E.F. Foley, A.A. Jazaeri, M.A. Shupnik, O. Jazaeri, and L.W. Rice Selective loss of oestrogen receptor beta in malignant human colon Cancer Res 60 2 2000 245 248 (Pubitemid 30070743)
83. J.P. Issa, Y.L. Ottaviano, P. Celano, S.R. Hamilton, N.E. Davidson, and S.B. Baylin Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon Nat Genet 7 4 1994 536 540 (Pubitemid 24308343)
84. M.L. Slattery, J.D. Potter, K. Curtin, S. Edwards, K.N. Ma, and K. Anderson Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer Cancer Res 61 1 2001 126 130 (Pubitemid 32095709)
85. L.Q. Xie, J.P. Yu, and H.S. Luo Expression of oestrogen receptor beta in human colorectal cancer World J Gastroenterol 10 2 2004 214 217
86. A.M. Carothers, S.A. Hughes, D. Ortega, and M.M. Bertagnolli 2-Methoxyestradiol induces p53-associated apoptosis of colorectal cancer cells Cancer Lett 187 1-2 2002 77 86 (Pubitemid 35279335)
87. N.L. Cho, S.H. Javid, A.M. Carothers, M. Redston, and M.M. Bertagnolli Oestrogen receptors alpha and beta are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/+ mice Cancer Res 67 5 2007 2366 2372 (Pubitemid 46437055)
88. V. Giroux, F. Lemay, G. Bernatchez, Y. Robitaille, and J.C. Carrier Oestrogen receptor beta deficiency enhances small intestinal tumorigenesis in ApcMin/+ mice Int J Cancer 123 2 2008 303 311 (Pubitemid 351842014)
89. V. Giroux, G. Bernatchez, and J.C. Carrier Chemopreventive effect of ERbeta-selective agonist on intestinal tumorigenesis in Apc(Min/+) mice Mol Carcinog 50 5 2011 359 369
90. N.B. Janakiram, V.E. Steele, and C.V. Rao Oestrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats Cancer Prev Res (Phila) 2 1 2009 52 59
91. C.C. Weige, K.F. Allred, and C.D. Allred Estradiol alters cell growth in nonmalignant colonocytes and reduces the formation of preneoplastic lesions in the colon Cancer Res 69 23 2009 9118 9124
92. J. Hartman, K. Edvardsson, K. Lindberg, C. Zhao, C. Williams, and A. Strom Tumor repressive functions of oestrogen receptor beta in SW480 colon cancer cells Cancer Res 69 15 2009 6100 6106
93. P. Protiva, H.S. Cross, M.E. Hopkins, E. Kallay, G. Bises, and E. Dreyhaupt Chemoprevention of colorectal neoplasia by oestrogen: potential role of vitamin D activity Cancer Prev Res (Phila) 2 1 2009 43 51
94. R.T. Chlebowski, J. Wactawski-Wende, C. Ritenbaugh, F.A. Hubbell, J. Ascensao, and R.J. Rodabough Oestrogen plus progestin and colorectal cancer in postmenopausal women N Engl J Med 350 10 2004 991 1004 (Pubitemid 38269276)
95. G. Heiss, R. Wallace, G.L. Anderson, A. Aragaki, S.A. Beresford, and R. Brzyski Health risks and benefits 3 years after stopping randomized treatment with oestrogen and progestin JAMA 299 9 2008 1036 1045 (Pubitemid 351347060)
96. G.L. Anderson, M. Limacher, A.R. Assaf, T. Bassford, S.A. Beresford, and H. Black Effects of conjugated equine oestrogen in postmenopausal women with hysterectomy: the women's health initiative randomized controlled trial JAMA 291 14 2004 1701 1712 (Pubitemid 38489892)
97. C. Ritenbaugh, J.L. Stanford, L. Wu, J.M. Shikany, R.E. Schoen, and M.L. Stefanick Conjugated equine estrogens and colorectal cancer incidence and survival: the women's health initiative randomized clinical trial Cancer Epidemiol Biomark Prev 17 10 2008 2609 2618
98. R.L. Prentice, M. Pettinger, S.A. Beresford, J. Wactawski-Wende, F.A. Hubbell, and M.L. Stefanick Colorectal cancer in relation to postmenopausal oestrogen and oestrogen plus progestin in the women's health initiative clinical trial and observational study Cancer Epidemiol Biomark Prev 18 5 2009 1531 1537